Latest / Santa Reads to You about Medicine

Tues 2026/10/06 Approach: Dementia, Part 2: Management
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
Part two of the dementia series, on management. It opens with the anti-amyloid antibodies, lecanemab and donanemab, working through CLARITY-AD and TRAILBLAZER-ALZ 2 in PICO form and spending real time on what the Clinical Dementia Rating Sum of Boxes measures, why a difference of about half a point becomes a "twenty-seven percent slowing," and how that compares with the smallest change patients and families notice. It covers ARIA and its ApoE4 gradient, the donanemab titration change, the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.